Literature DB >> 25178163

The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.

S Oz1, O Kapitansky1, Y Ivashco-Pachima1, A Malishkevich1, E Giladi1, N Skalka2, R Rosin-Arbesfeld2, L Mittelman3, O Segev4, J A Hirsch5, I Gozes6.   

Abstract

The NAP motif of activity-dependent neuroprotective protein (ADNP) enhanced memory scores in patients suffering from mild cognitive impairment and protected activities of daily living in schizophrenia patients, while fortifying microtubule (MT)-dependent axonal transport, in mice and flies. The question is how does NAP fortify MTs? Our sequence analysis identified the MT end-binding protein (EB1)-interacting motif SxIP (SIP, Ser-Ile-Pro) in ADNP/NAP and showed specific SxIP binding sites in all members of the EB protein family (EB1-3). Others found that EB1 enhancement of neurite outgrowth is attenuated by EB2, while EB3 interacts with postsynaptic density protein 95 (PSD-95) to modulate dendritic plasticity. Here, NAP increased PSD-95 expression in dendritic spines, which was inhibited by EB3 silencing. EB1 or EB3, but not EB2 silencing inhibited NAP-mediated cell protection, which reflected NAP binding specificity. NAPVSKIPQ (SxIP=SKIP), but not NAPVAAAAQ mimicked NAP activity. ADNP, essential for neuronal differentiation and brain formation in mouse, a member of the SWI/SNF chromatin remodeling complex and a major protein mutated in autism and deregulated in schizophrenia in men, showed similar EB interactions, which were enhanced by NAP treatment. The newly identified shared MT target of NAP/ADNP is directly implicated in synaptic plasticity, explaining the breadth and efficiency of neuroprotective/neurotrophic capacities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178163     DOI: 10.1038/mp.2014.97

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  75 in total

Review 1.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

2.  Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein).

Authors:  Tatiana Stepanova; Jenny Slemmer; Casper C Hoogenraad; Gideon Lansbergen; Bjorn Dortland; Chris I De Zeeuw; Frank Grosveld; Gert van Cappellen; Anna Akhmanova; Niels Galjart
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 3.  The tubulin code.

Authors:  Kristen J Verhey; Jacek Gaertig
Journal:  Cell Cycle       Date:  2007-06-26       Impact factor: 4.534

4.  Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.

Authors:  Efrat Dresner; Galila Agam; Illana Gozes
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-03       Impact factor: 4.600

Review 5.  Regulation of EB1/3 proteins by classical MAPs in neurons.

Authors:  C L Sayas; Jesús Avila
Journal:  Bioarchitecture       Date:  2014-01-10

6.  Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.

Authors:  Ki Shuk Shim; Gert Lubec
Journal:  Neurosci Lett       Date:  2002-05-24       Impact factor: 3.046

7.  Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model.

Authors:  Anat Idan-Feldman; Yulie Schirer; Eleni Polyzoidou; Olga Touloumi; Roza Lagoudaki; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Neurobiol Dis       Date:  2011-07-27       Impact factor: 5.996

8.  Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.

Authors:  Sharon Furman; Ruth A Steingart; Shmuel Mandel; Janet M Hauser; Douglas E Brenneman; Illana Gozes
Journal:  Neuron Glia Biol       Date:  2004-08

9.  A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease.

Authors:  Yasuji Matsuoka; Yan Jouroukhin; Audrey J Gray; Li Ma; Chiho Hirata-Fukae; Hui-Fang Li; Li Feng; Laurent Lecanu; Benjamin R Walker; Emmanuel Planel; Ottavio Arancio; Illana Gozes; Paul S Aisen
Journal:  J Pharmacol Exp Ther       Date:  2008-01-16       Impact factor: 4.030

Review 10.  From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.

Authors:  Illana Gozes; Inna Divinsky; Inbar Pilzer; Mati Fridkin; Douglas E Brenneman; Avron D Spier
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more
  52 in total

1.  International Meeting Molecular Neurodegeneration: News and Views in Molecular Neuroscience in Health and Disease. Delmenhorst, Germany, July 20-22, 2015.

Authors:  Illana Gozes; Peter W Baas; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2015-10       Impact factor: 3.444

Review 2.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

3.  Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.

Authors:  Xian-Cang Ma; Zheng Chu; Xiao-Ling Zhang; Wen-Hui Jiang; Min Jia; Yong-Hui Dang; Cheng-Ge Gao
Journal:  Neurochem Res       Date:  2016-02-04       Impact factor: 3.996

4.  ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.

Authors:  Anna Malishkevich; Janina Leyk; Olaf Goldbaum; Christiane Richter-Landsberg; Illana Gozes
Journal:  J Mol Neurosci       Date:  2015-10       Impact factor: 3.444

5.  Tau Diagnostics and Clinical Studies.

Authors:  Illana Gozes; Günter Höglinger; James P Quinn; Nigel M Hooper; Kina Höglund
Journal:  J Mol Neurosci       Date:  2017-10       Impact factor: 3.444

6.  The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey--ADNP Mutation.

Authors:  Illana Gozes; Celine Helsmoortel; Geert Vandeweyer; Nathalie Van der Aa; Frank Kooy; Sandra Bedrosian-Sermone
Journal:  J Mol Neurosci       Date:  2015-08       Impact factor: 3.444

7.  Developmental Phenotype of the Rare Case of DJ Caused by a Unique ADNP Gene De Novo Mutation.

Authors:  Joseph Levine; David Cohen; Carole Herman; Alain Verloes; Vincent Guinchat; Lautaro Diaz; Cora Cravero; Anne Mandel; Illana Gozes
Journal:  J Mol Neurosci       Date:  2019-07       Impact factor: 3.444

8.  A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region.

Authors:  Xiaohua Liu; John R Kelsoe; Tiffany A Greenwood
Journal:  J Affect Disord       Date:  2015-09-25       Impact factor: 4.839

9.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

Review 10.  Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.

Authors:  Keshav Anand; Marwan Sabbagh
Journal:  Expert Opin Investig Drugs       Date:  2015-08-01       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.